ENOVIS CORP (ENOV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ENOV - US1940141062 - Common Stock
26.76 USD
-0.26 (-0.96%)
26.76 USD
0 (0%)
Taking everything into account, ENOV scores 4 out of 10 in our fundamental rating. ENOV was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While ENOV is still in line with the averages on profitability rating, there are concerns on its financial health. ENOV is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year ENOV was profitable.
In the past year ENOV had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ENOV reported negative net income in multiple years.
ENOV had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of -30.84%, ENOV perfoms like the industry average, outperforming 43.32% of the companies in the same industry.
ENOV's Return On Equity of -67.66% is in line compared to the rest of the industry. ENOV outperforms 45.99% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.12%, ENOV is in the better half of the industry, outperforming 65.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROIC | 0.12% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 0.25%, ENOV is doing good in the industry, outperforming 65.24% of the companies in the same industry.
In the last couple of years the Operating Margin of ENOV has declined.
ENOV has a Gross Margin of 57.19%. This is comparable to the rest of the industry: ENOV outperforms 56.15% of its industry peers.
In the last couple of years the Gross Margin of ENOV has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% |
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ENOV is destroying value.
The number of shares outstanding for ENOV has been increased compared to 1 year ago.
The number of shares outstanding for ENOV has been increased compared to 5 years ago.
Compared to 1 year ago, ENOV has a worse debt to assets ratio.
2.2 Solvency
ENOV has an Altman-Z score of 0.78. This is a bad value and indicates that ENOV is not financially healthy and even has some risk of bankruptcy.
ENOV has a Altman-Z score (0.78) which is in line with its industry peers.
ENOV has a debt to FCF ratio of 59.72. This is a negative value and a sign of low solvency as ENOV would need 59.72 years to pay back of all of its debts.
The Debt to FCF ratio of ENOV (59.72) is better than 67.91% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that ENOV is somewhat dependend on debt financing.
The Debt to Equity ratio of ENOV (0.66) is worse than 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Altman-Z | 0.78 |
ROIC/WACC0.02
WACC7.22%
2.3 Liquidity
ENOV has a Current Ratio of 2.22. This indicates that ENOV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.22, ENOV is in line with its industry, outperforming 41.71% of the companies in the same industry.
ENOV has a Quick Ratio of 1.16. This is a normal value and indicates that ENOV is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.16, ENOV is not doing good in the industry: 71.12% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
ENOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.14%, which is quite impressive.
The earnings per share for ENOV have been decreasing by -16.18% on average. This is quite bad
The Revenue has grown by 11.57% in the past year. This is quite good.
ENOV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.73% yearly.
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
3.2 Future
ENOV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.19% yearly.
Based on estimates for the next years, ENOV will show a quite strong growth in Revenue. The Revenue will grow by 8.87% on average per year.
EPS Next Y14.56%
EPS Next 2Y11.4%
EPS Next 3Y11.38%
EPS Next 5Y23.19%
Revenue Next Year7.42%
Revenue Next 2Y5.98%
Revenue Next 3Y5.8%
Revenue Next 5Y8.87%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 8.04, which indicates a very decent valuation of ENOV.
Based on the Price/Earnings ratio, ENOV is valued cheaply inside the industry as 96.26% of the companies are valued more expensively.
ENOV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.49.
The Price/Forward Earnings ratio is 7.62, which indicates a rather cheap valuation of ENOV.
ENOV's Price/Forward Earnings ratio is rather cheap when compared to the industry. ENOV is cheaper than 97.86% of the companies in the same industry.
ENOV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.69.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.04 | ||
| Fwd PE | 7.62 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ENOV is valued cheaper than 91.98% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ENOV is valued a bit cheaper than the industry average as 71.66% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 67.23 | ||
| EV/EBITDA | 9.65 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.55
PEG (5Y)N/A
EPS Next 2Y11.4%
EPS Next 3Y11.38%
5. Dividend
5.1 Amount
No dividends for ENOV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
26.76
-0.26 (-0.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners117.5%
Inst Owner Change-2.39%
Ins Owners1.2%
Ins Owner Change0.83%
Market Cap1.53B
Revenue(TTM)2.23B
Net Income(TTM)-1.37B
Analysts83.75
Price Target49.07 (83.37%)
Short Float %13.78%
Short Ratio10.46
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.55%
Min EPS beat(2)7.76%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)8.22%
Min EPS beat(4)4.97%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)7.21%
EPS beat(12)12
Avg EPS beat(12)8.15%
EPS beat(16)16
Avg EPS beat(16)8.66%
Revenue beat(2)0
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.81%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)5
Avg Revenue beat(16)-4.71%
PT rev (1m)-7.03%
PT rev (3m)-11.45%
EPS NQ rev (1m)-0.37%
EPS NQ rev (3m)-5.55%
EPS NY rev (1m)1.75%
EPS NY rev (3m)1.73%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)-1.34%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.04 | ||
| Fwd PE | 7.62 | ||
| P/S | 0.69 | ||
| P/FCF | 67.23 | ||
| P/OCF | 7.05 | ||
| P/B | 0.76 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.65 |
EPS(TTM)3.33
EY12.44%
EPS(NY)3.51
Fwd EY13.13%
FCF(TTM)0.4
FCFY1.49%
OCF(TTM)3.8
OCFY14.18%
SpS39.05
BVpS35.33
TBVpS-8.37
PEG (NY)0.55
PEG (5Y)N/A
Graham Number51.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROCE | 0.15% | ||
| ROIC | 0.12% | ||
| ROICexc | 0.12% | ||
| ROICexgc | 0.34% | ||
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% | ||
| FCFM | 1.02% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-45.54%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.8%
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
F-Score4
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Debt/EBITDA | 4.5 | ||
| Cap/Depr | 66.6% | ||
| Cap/Sales | 8.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.98% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 | ||
| Altman-Z | 0.78 |
F-Score4
WACC7.22%
ROIC/WACC0.02
Cap/Depr(3y)55.91%
Cap/Depr(5y)50.8%
Cap/Sales(3y)7.49%
Cap/Sales(5y)6.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
EPS Next Y14.56%
EPS Next 2Y11.4%
EPS Next 3Y11.38%
EPS Next 5Y23.19%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
Revenue Next Year7.42%
Revenue Next 2Y5.98%
Revenue Next 3Y5.8%
Revenue Next 5Y8.87%
EBIT growth 1Y-35.24%
EBIT growth 3YN/A
EBIT growth 5Y-48.51%
EBIT Next Year76.5%
EBIT Next 3Y28.12%
EBIT Next 5Y28.11%
FCF growth 1Y122.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y609.06%
OCF growth 3Y-31.69%
OCF growth 5Y-2.82%
ENOVIS CORP / ENOV FAQ
What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ENOV.
Can you provide the valuation status for ENOVIS CORP?
ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.
Can you provide the profitability details for ENOVIS CORP?
ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.
What is the earnings growth outlook for ENOVIS CORP?
The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 14.56% in the next year.